Skip to main content
KNC Laboratories Co., Ltd. logo

KNC Laboratories Co., Ltd. — Investor Relations & Filings

Ticker · 6568 ISIN · JP3290400005 LEI · 353800O5AV29ESWX8629 T Manufacturing
Open in API
Filings indexed 49 across all filing types
Latest filing 2019-02-12 Interim / Quarterly Rep…
Country JP Japan
Listing T 6568

About KNC Laboratories Co., Ltd.

https://www.kncweb.co.jp/en/

KNC Laboratories Co., Ltd. specializes in research, development, and production solutions for organic chemicals and biochemicals. The company provides comprehensive contract R&D and manufacturing services that cover the entire product lifecycle, from early-stage research and drug discovery to commercial production. Core offerings include custom synthesis of organic compounds, process development, scale-up, and Good Manufacturing Practice (GMP) compliant production of clinical trial drugs. KNC Laboratories serves a diverse range of high-technology sectors, including the pharmaceutical, electronic materials, chemical, agrochemical, energy, and environmental industries. It offers flexible service models such as Original Equipment Manufacturer (OEM), R&D-driven manufacturing, and Fee-for-Time/Full-Time Equivalent (FTE) contracts to meet specific client requirements.

Recent filings

Filing Released Lang Actions
四半期報告書－第35期第3四半期(2018/10/01－2018/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 35th fiscal period, filed with the Kinki Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet and income statement, as well as management analysis and notes to the financial statements. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-02-12 Japanese
四半期報告書－第35期第2四半期(2018/07/01－2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kinki Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement for the second quarter of the 35th fiscal year (ending September 30, 2018). It includes audit review information and management analysis, fitting the definition of an Interim/Quarterly Report (IR). H1 2019
2018-11-12 Japanese
四半期報告書－第35期第1四半期(2018/04/01－2018/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for KNC Laboratories Co., Ltd. for the first quarter of the 35th fiscal year (April 1, 2018, to June 30, 2018). It contains detailed financial statements, including the balance sheet and income statement, and management's analysis of financial results. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q1 2018
2018-08-10 Japanese
有価証券報告書－第34期(平成29年4月1日－平成30年3月31日)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial data, management discussion, and corporate information for the fiscal year ending March 31, 2018. It is a formal regulatory filing submitted to the Kinki Finance Bureau under the Financial Instruments and Exchange Act. FY 2018
2018-06-28 Japanese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.